Barings European Loan Fund
ISIN:IE00BKWP5G39
as of 30/04/2020
as of 30/04/2020
as of 30/04/2020
as of 30/04/2020
19.50% Amérique du Nord
0.91% Rest of World
Fund Facts
| Type de fond | Qualifying Investor Alternative Investment Fund |
| Date de création | 31/08/2011 |
| Domicile | Irlande |
| Classe d'actifs | Obligations à Taux Fixe |
| Distributions | Quarterly |
| Dealing Frequency | Daily |
Classes disponibles
| Share Class | E |
| ISIN | IE00BKWP5G39 |
| Devise | SGD |
| Accumulating / Distributing | Distributing |
| Share Class Inception Date | 23/05/2014 |
| Admin., Depository & Operating Expenses | Capped at 12.5bps per annum |
| Management Charges | 1.00% |
Objective
The Barings European Loan Fund seeks to provide investors with current income and, where appropriate, capital appreciation.
Strategy
The Barings European Loan Fund seeks to achieve its objective by investing primarily in senior secured loans, as well as in senior secured notes issued by European companies. The Fund will also invest, to a lesser extent, in senior secured loans and senior bonds issued by North American companies (subject to a limit of 20% of Net Asset Value).
Who Should Invest
The Fund is designed for investors seeking to benefit from a strategy that provides high current income generation and, where appropriate, capital appreciation.
Risks
The value of investments and the income they provide can fall as well as rise and investors may not get back the amount originally invested. The Fund invests in high yield bonds. The value of these investments tends to be more volatile than investment grade bonds.
The information available on this website is not an offer to sell or an invitation to apply for this product and is by way of information only, nor is the information available on this website intended as an offering of this product to US Persons. Depending on your jurisdiction, you may not have access to this product. Individual investors should contact their financial advisor before investing in this product. The Key Investor Information Document (KIID), if applicable, must be received and read before investing. All other relevant documents relating to the product such as the Report and Accounts and Prospectus should also be read. The information available on this website does not constitute investment, tax, legal or other advice or recommendation.
Portefeuille as of 30/04/2020
Average Duration
0.42 yrs
Number of Issuers
138 issuers
Portfolio Assets Composition
Quality Distribution
| Ratings | % of Assets |
| BA | 2.45% |
| B | 70.00% |
| CAA AND BELOW | 15.20% |
| NR | 12.30% |
| Total | 99.95% |
Top 5 Countries
| Country | % of Assets |
| ROYAUME-UNI | 27.33% |
| GERMANY | 19.54% |
| ETATS-UNIS | 19.50% |
| FRANCE | 9.17% |
| PAYS-BAS | 8.29% |
| Total | 83.83% |
Top 10 Holdings
| Holding | % of Assets |
| ENDEMOL | 4.20% |
| VERITAS | 3.85% |
| FLINT GROUP | 2.89% |
| ADVANZ PHARMA | 2.44% |
| VERISURE | 1.78% |
| SPRINGER NATURE | 1.77% |
| DOUGLAS | 1.65% |
| COGNITA | 1.63% |
| LIFESCAN GLOBAL | 1.61% |
| ION TRADING TECHNOLOGIES | 1.38% |
| Total | 23.20% |
Documents
-
Fiche de performance
-
Documents sur le fonds
En utilisant notre site web Barings.com, vous acceptez (1) que nous pouvons utiliser certains cookies sur votre appareil ainsi que d'autres outils de suivi en ligne comme expliqué dans nos Termes et Conditions et Confidentialité du site et (2) vous acceptez les Termes et Conditions.
Welcome to Barings. We have organized the information on our website to be specific to the needs of the global investor community, and also to reflect the needs of investors across different regions of the world we serve.
Merci de choisir votre localisation
Merci de choisir votre localisation